This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogen
This DLEC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 879-908 amino acids from the Central region of human DLEC1.
DLEC1
Reactivity: Human
ELISA, WB
Host: Rabbit
Polyclonal
FITC
Application Notes
For WB starting dilution is: 1:1000
Restrictions
For Research Use only
Format
Liquid
Concentration
0.5 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target
DLEC1
(Deleted in Lung and Esophageal Cancer 1 (DLEC1))
DLC1 antibody, F56 antibody, D630005C06Rik antibody, deleted in lung and esophageal cancer 1 antibody, deleted in lung and esophageal cancer protein 1 antibody, DLEC1 antibody, LOC100187070 antibody, Dlec1 antibody
Background
This gene contains 37 exons, spans approximately 59-kb, and is located in the 3p22-p21.3 chromosomal segment that is commonly deleted in various carcinomas. Several alternatively spliced transcripts have been observed that contain disrupted coding regions and likely encode nonfunctional proteins. Aberrant transcription of this gene may be involved in carcinogenesis of the lung, esophagus, and kidney.